|Articles|January 5, 2023

Egnyte Announces New Offering for Early-Stage Life Science Startups

Company provides startup biotechs access to collaboration platform for a year.

Egnyte announced it will be providing early-stage life sciences innovators complimentary access to their Egnyte for Life Sciences platform. This offer is designed to accelerate “time to patient” for life sciences innovators and will give companies a full year of access to Egnyte’s platform.

Read more about the new offering here.

Newsletter

Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.

Subscribe Now!

Related Content